Optical methods for readout and signal transduction have many advantages in point-of-care (“POC”) diagnostic tests, including compatibility with benchtop assays, environmental stability, and potential for multiplexed detection of several targets. However, POC test developers currently lack access to high quality, low-cost optics, compatible with fluorescence, scattering, reflectance, or transmission assays. As a result, most lateral flow assays provide only a binary “yes or no” diagnosis, and microfluidic cartridges still require a traditional microscope or bulky reader for readout. In order to overcome this barrier and advance the utility and performance of current and emerging POC diagnostics, a high quality, cost-effective optical readout and signal transduction component is required.
Anemia provides an example of the need for low-cost point-of-care diagnostic tests. Hemoglobin concentration assessment is the most commonly performed laboratory test worldwide, driven by the impact of anemia, and is necessary for all healthcare systems. Anemia affects an estimated quarter of the world's population and can be caused by iron deficiency, malnutrition, blood loss, and infectious diseases (e.g. malaria, hookworm, tuberculosis, HIV), among others. Anemia can cause delayed mental and physical development, fatigue, decreased work productivity, and increased risk of mortality, especially during childbirth. The condition is diagnosed by measuring the concentration of hemoglobin in the blood. Once the condition is diagnosed, the underlying cause can be determined and treated with, for example, iron supplements, anti-malarial drugs, or blood transfusions. As such, hemoglobin concentration assessment at the point-of-care enables clinicians to make rapid decisions about treatment resulting in improved medical care.
The present disclosure generally relates to systems and methods for diagnostic testing. More particularly, the present disclosure relates to system and methods for point of care diagnostic testing using signal transduction.
In one embodiment, the present disclosure provides a readout and signal transduction (ROST) component. The ROST includes a universal fixture adapted to receive and align one or more optical elements and one or more opto-mechanical elements, wherein the optical elements and one or more opto-mechanical elements are stacked in the universal fixture, one or more optical elements configured for integration into the universal fixture; and one or more opto-mechanical elements configured for integration into the universal fixture.
The present disclosure also provides a method for analyzing a sample. The method includes providing a readout and signal transduction (ROST) component, which includes a universal fixture adapted to receive and align one or more optical elements and one or more opto-mechanical elements, wherein the optical elements and one or more opto-mechanical elements are stacked in the universal fixture; one or more optical elements configured for integration into the universal fixture; one or more opto-mechanical elements configured for integration into the universal fixture; and a sample platform to accept and hold a sample for analysis. The method further includes putting an analyte on the sample platform and analyzing the analyte using the ROST component.
The features and advantages of the present invention will be apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.
Some specific example embodiments of the disclosure may be understood by referring, in part, to the following description and the accompanying drawings.
While the present disclosure is susceptible to various modifications and alternative forms, specific example embodiments have been shown in the figures and are herein described in more detail. It should be understood, however, that the description of specific example embodiments is not intended to limit the invention to the particular forms disclosed, but on the contrary, this disclosure is to cover all modifications and equivalents as illustrated, in part, by the appended claims.
The present disclosure generally relates to systems and methods for diagnostic testing. More particularly, the present disclosure relates to system and methods for point of care diagnostic testing using signal transduction.
Certain implementations feature a high performance, low cost optical readout and signal transduction (ROST) component for point of care (POC) diagnostic assays, which is modular, robust, reconfigurable, and highly scalable in volume. Certain example ROST include a universal fixture designed to accept interrogation units for illumination and light collection which can operate in multiple measurement modes, including transmission, reflectance, scattering, and fluorescence, in a single spectral band or in multiple bands.
The schematic view 102 of the example ROST shown in
In certain implementations the interrogation units are assembled from a standardized library of optical and opto-mechanical elements that stack inside the fixture without alignment. The fixture is configured to accept interrogation units arranged in any pattern, permitting easy customization for a wide variety of existing and new sample platforms without the need for complicated and expensive redesign.
Certain implementations feature optical readout and signal transduction (ROST) components for POC diagnostic assays. The ROST component consists of a universal fixture designed to accept interrogation units for illumination and light collection which can operate in multiple measurement modes, including transmission, reflectance, scattering, and fluorescence, in a single spectral band or in multiple bands. The ROST component is highly modular. Interrogation units are assembled from a standardized library of optical and opto-mechanical elements that stack inside the fixture without alignment. The fixture is designed to accept interrogation units arranged in any pattern, permitting customization for a wide variety of existing and new sample platforms without the need for complicated and expensive redesign.
Certain implementations use semiconductor-based light sources and digital CMOS array detectors, harnessing their increasing performance levels, shrinking footprints, and falling costs in the consumer market-driven sector of the opto-electronics industry. Example implementations include one or more mass-fabricated, small-scale, optical and opto-mechanical elements (
Example implementations may be used in the readout stage of POC diagnostic tests. Example ROSTs are applicable for all assays with optical readout. The universal fixture is designed for integration with a variety of assay platforms, including paper, plastic, and glass. The ROST component is adaptable to a diverse range of targets (e.g. metabolite, protein, nucleic acid, organism) and sample types (e.g. stool, serum, saliva). Example interrogation units are for a variety of measurement modes, including transmission, reflectance, light scattering and fluorescence. Example components allow the incorporation of polarization-sensitive and multispectral analysis within these modes. Interrogation units can operate at multiple spatial resolution scales, ranging from diffraction-limited imaging to simple spatial integration of signal across an entire measurement channel. These modes provide the ability to detect and quantify commonly used optical labels, including colorimetric dyes, polystyrene microspheres loaded with absorbing or fluorescent dyes, fluorescent dyes and molecular beacons, metallic nanoparticles, and semiconductor nanocrystals. As shown in
The sensitivity of example ROST is primarily dependent on the signal-to-noise ratio and the signal-to-background ratio which can be achieved. While these depend on the choice of label, amount of target present, degree of background interferrant, system throughput, and detector characteristics, example models quantitatively analyze optical throughput and relate this to limits of detection for particular assay conditions. One example optical label is an oligonucleotide-targeted gold nanoparticles to detect the presence of cryptosporidium in stool samples.
In the example of
In certain implementations, the optical elements are held in pace using opto-mechanical mounts which are made using a lithographic process. For example, the opto-mechanical components may be fabricated with X-ray (DXRL) or UV-lithography. In certain implementations, the universal fixture is made using injection molding.
Low-cost, mass-production methods are capable of generating high-quality miniature-scale optical elements as evidenced by the ubiquitous presence of cameras in cell phones, and other portable electronic devices. We have shown that the same methods are also capable of generating relatively more challenging microscope optics for commercial products. Certain implementations of the present disclosure may yield a new, modular design approach to build a reusable ROST component that is more sensitive, robust, compact, power efficient, and cheaper than large-scale counterparts and that can easily be customized to interface with a wide variety of POC sample platforms. An exemplary ROST component is based on a universal fixture to accommodate interrogation units in an arbitrary pattern is shown in
In certain example implementations, each interrogation unit is comprised of standardized optical elements and miniature opto-mechanical mounting elements which are stacked within tubes in the fixture as shown in
In certain implementations, all components are mounted inside the fixture using a proven zero-alignment microscopic optical-system concept. In practical terms, the zero-alignment concept translates into assembly errors that are smaller than the tolerances on the performance of the optical system. No, or minimal, adjustment is needed and assembly works in a “plug & sense” fashion. Certain implementations of the present disclosure, rely on two advanced manufacturing techniques to fabricate high-performance, low-cost “plug & sense” interrogation units. Example miniature plastic optical elements will be manufactured using injection molding. An advantage of injection molding is that it permits the use of aspheric surfaces, requiring fewer lens elements in an interrogation unit for the optimum optical quality. Moreover, injection molding may allow for extremely low per-element costs at high volume. Diamond turning can be used to rapidly fabricate prototype elements in low volume at reasonable cost and, once perfected, molds for injection molding of such parts. Just as lens elements can be miniaturized, so can optomechanical mounts. Certain implementations employ ultra-precise deep X-ray or UV lithography to manufacture such mounts in a batch mode as shown in
Example optomechanical mounts can include precision features such as external and internal springs to compensate for variations in the outer diameter of optical elements or the
inner diameter of slots in the universal fixture, and self-center multiple elements. Table 4 shows example functional parameters of the ROST component, as well as example optical elements and optomechanical elements and example manufacturing technologies which may be used to manufacture the optical and opto-mechanical elements.
Bacillus
anthracis (RNA) in lateral flow
S.
aureus (DNA)
Cryptosporidium (DNA/RNA)
Rhodamine (staining M.Tuberculosis)
In certain implementations, biomedically relevant reference standards are used to test ROST components. Table 5 lists example candidate materials for each modality as well as references citing relevant concentration levels for biomedically relevant targets.
Certain implementations include one or more interrogation units for illumination, transmission, reflectance, light scattering, and fluorescence modes. Certain implementations include one or more optical multiplexers. Example interrogation units are for generation and collection of optical signals in several modalities, including, but not limited to transmission, reflectance, light scattering, and fluorescence modes. Optical multiplexers are components that will permit parallel illumination and signal collection from multiple distributed regions of a diagnostic test. Interrogation units and optical multiplexers will be fabricated within this objective and tested for optical performance at the individual component level using recognized optical standards.
Example interrogation units for the ROST component may originate from a base catalog of individual components, allowing for distinct interrogation units to be developed in a cost-efficient process.
The design parameters for individual components (for example, lens diameter, thickness, and curvature) may be based on the needs of the system and its application. In certain implementations, tolerances for interrogation units for nonimaging-based diagnostic tests (those purely requiring efficient light collection) may be less stringent than for the high-resolution imaging previously demonstrated (
The highly modular approach of the ROST component may be extended to the individual component level (
Example interrogation units are for sample illumination and optical signal collection from a single region within a diagnostic test. (The test may be a lateral flow strip, a microfluidic cartridge, or other format, but the diagnostically relevant information is confined to a single spatial region). Example individual lens elements (
Example ROST elements are for multiplexed analysis. In these elements, optical multiplexers enable simultaneous evaluation of multiple regions within a single diagnostic test. (These elements could be applied to evaluate discrete capture lines on a lateral flow strip, or separate chambers in a microfluidic cartridge, for example). Example optical multiplexers enable simultaneous illumination of multiple test regions with a single optical light source. Other example optical multiplexers enable simultaneous collection of optical signals from multiple test regions for delivery to a single detector.
Example implementations of the present disclosure further use signal processing tools for detection in multiple modalities. In certain implementations a step-wise strategy is used to design signal processing modules that can be combined in flexible ways to yield desired output signals and to characterize signal-to-noise levels, signal-to-background ratios, minimum assay detection limits, assay linearity, and assay dynamic range.
Development may include defining the type of signal to be measured; identifying sources of variation in signal associated with both target and background; and developing analog/digital processing tools to yield calibrated signals. In certain implementations, the desired output signal type for each measurement mode is determined. Using suitable detectors, experimental testing may be performed using single-channel interrogation units to identify necessary calibration signals to be collected, including, but not limited to: source intensity/power, ambient light levels, and system throughput. The process may further include developing signal processing strategies to extract desired output signals, calibrated for environmental variations. An approach based on a single interrogation channel, is straightforward, and enables a user to characterize the sensitivity, specificity, and dynamic range of each modality. In other implementations, by combining information from multiple channels, internal control channels may be integrated to better compensate for environmental variations and for the presence of interferrants.
In certain implementations ROST calibration units are included in the universal fixture.
Example implementations include a Single field of view ROST where optical illumination and signal collection is performed from a single site on the assay; for example a color indicator bar on a lateral flow test. Another example implementation is a distributed field of view ROST where optical illumination and signal collection is from multiple sites on the assay; for example reading fluorescence from multiple chambers of a microfluidic card. Another example implementation is a continuous field of view ROST where optical illumination and signal collection is from a near continuous region of the assay; for example examination of brightfield or fluorescence images across a large region of a microfluidic card or a malaria or tuberculosis smear.
It is noted that embodiments of the present invention may be used for both imaging and non-imaging applications. Some examples of the non-imaging applications contemplated for the invention include hemoglobinometers, colorimetric assays, and Fluorescence assays. Some examples of imaging applications of the invention relate to imaging biological samples and bead based assays. It is appreciated that there may be many other applications for the present invention.
To facilitate a better understanding of the present disclosure, the following examples of certain aspects of some embodiments are given. In no way should the following examples be read to limit, or define, the entire scope of the disclosure.
Chromatography paper may be a low-cost, rugged, and self-contained medium for microfluidic assays in point-of-care systems suitable for developing countries. The ubiquitous and low-cost nature of chromatography paper represents an alternative to expensive plastic cuvettes used in other systems such as HemoCue. An objective of this example is to investigate if chromatography paper can serve as a low-cost medium for accurate spectrophotometric detection of blood hemoglobin concentration.
In order to validate a paper-based spectrophotometric hemoglobin assessment, we performed experiments to optimize or evaluate sensitivity to five parameters: impregnating paper with chemicals to lyse red blood cells, paper type, drying time, wavelengths measured, and volume of blood. Blood and plasma samples were obtained via venous draw from healthy donors who gave informed consent; plasma was also purchased from the Gulf Coast Regional Blood Bank (Houston, Tex.). Protocols were reviewed and approved by the Institutional Review Board at Rice University. For these experiments, whole blood was diluted with plasma to simulate anemia. Micropipettes were used to spot blood on paper to simulate touching a patient's fingertip to the paper after a fingerprick. A benchtop spectrophotometer (Cary 5000 UV-VIS) recorded the spectra of the samples via an on-axis collimated transmission measurement. The samples were masked with a 3 mm×3 mm aperture. Gehring et al. have reported the HemoCue 201+ to be accurate to within approximately 0.5 g/dL of the reference method in a laboratory setting (H. Gehring, et al., Acta Anaesthesiologica Scandinavica, 2002, 46, 980-6.), so it was used as a standard for the evaluation of the chromatography paper medium. Values from the spectrum of blood spotted on paper were correlated with the hemoglobin concentration of the sample obtained with a HemoCue.
Seven filter and chromatography papers from Whatman PLC (United Kingdom)—chromatography papers Chr1, Chr3MM, Chr4, and grades 2, 4, 5, and 6 filter paper—were evaluated for (1) the qualitative appearance of uniform spreading of blood spotted on the paper and (2) the repeatability of spectrophotometric measurements of blood samples with high and low hemoglobin concentrations. Paper strips were treated with 10 μL 4% (w/v) sodium deoxycholate in PBS and allowed to dry. 10 μL of blood was applied and spectra were taken 2 minutes after spotting. For each type of paper, three measurements were made of blood with a low hemoglobin concentration (7-8 g/dL) and three of blood with a high hemoglobin concentration (15-16 g/dL). The measurements of Chr4 had the lowest standard deviation for both hemoglobin concentrations for papers where blood spread quickly and with little pooling. Chr4 was used for all other experiments.
We examined whether hemolysis affected the variability of light transmitted through paper spotted with blood. In general, blood spread more uniformly and transmission measurements from unlysed blood (
We examined whole blood samples as well as samples where red blood cells were mechanically lysed or chemically lysed with sodium deoxycholate. To achieve mechanical lysis, whole blood was taken through multiple (>3) freeze-thaw cycles (−20° C. to 20° C.). The blood was considered lysed if high-speed centrifugation did not separate the blood into plasma and red blood cell layers and microscopy showed no intact cells.
To achieve chemical lysis of whole blood spotted on paper, we used the detergent sodium deoxycholate. To evaluate the amount of sodium deoxycholate needed to achieve lysis on paper, paper strips were treated with various volumes (10, 20, 30, 40, and 50 μL) of 2% or 4% (w/v) sodium deoxycholate in PBS. After the sodium deoxycholate dried, 10 μL whole blood was applied to the treated paper. Unlysed blood and mechanically lysed blood applied to untreated paper served as controls. The blood dried for 2 minutes and was then eluted from the paper in 1 mL PBS for 10 minutes. The paper was removed and the spectrum of the remaining solution was taken on a Cary 5000 UV/VIS spectrophotometer from 350 nm to 800 nm. Blood was considered lysed if its transmission spectra did not show evidence of the turbidity associated with intact red blood cells. 10 μL of 4% (w/v) sodium deoxycholate was chosen for all further experiments because (1) it resulted in effective lysis and (2) the blood spread quickly and evenly on the paper without pooling.
To assess the effect of red blood cell lysis on the accuracy of hemoglobin concentration derived from spectral measurements, we measured transmission spectra of samples with varying concentrations of hemoglobin for three conditions: unlysed blood applied to untreated Chr4 paper, mechanically lysed blood applied to untreated Chr4 paper, and unlysed blood applied to sodium deoxycholate-treated Chr4 paper. Blood from 4 donors was diluted with plasma to obtain a range of hemoglobin concentrations spanning the physiologic range. The experiment was repeated on two days for each condition; half of the data was used as a training set, and the remaining data were used as a validation set. The training set for each condition was used to develop an algorithm relating hemoglobin concentration as measured by HemoCue to the absorbance difference at two wavelengths as described herein. This relationship was used to calculate the hemoglobin concentration of samples in each validation set, and the calculated hemoglobin concentrations were compared to the concentrations obtained from HemoCue.
To determine the effects of drying time and to select optimal wavelengths for determining hemoglobin concentration, absorption spectra of whole blood spotted on sodium deoxycholate-treated Chr4 paper were collected from 350 nm to 800 nm over the course of 30 minutes, the time during which a hemoglobin concentration assessment could reasonably be performed in the field. Blood samples from four donors were used, and spectra were taken every 2 minutes. This data helped determine which spectral measurements could be used to calculate consistent hemoglobin concentrations even if the drying time of the spot varied, an important factor for point-of-care use.
The difference in optical density between various pairs of wavelengths was plotted versus time, and a training set, an example of which is described herein, was used to calculate hemoglobin concentration. The algorithm was derived from training set spectra taken 2 minute after spotting; this algorithm was used to calculate hemoglobin concentration at each time point.
Some pairs of wavelengths may give results that are stable over time, such as the difference between 528 nm and 656 nm (an average increase of 1.5 g/dL over 30 min.,
For the remainder of the experiments, spectra were taken at 2 minute after spotting and the absorbance difference between 528 nm and 656 nm was used to calculate hemoglobin concentration and compare to results determined by HemoCue.
Because the volume of blood in a finger-prick can vary, we examined how sensitive our method was to changes in blood spot volume. Absorption spectra of various volumes (5, 10, 15, 20, 25 μL) of whole blood on sodium deoxycholate-treated Chr4 paper were obtained to determine the effects of blood volume on the test. (
The calculated hemoglobin concentrations for all volumes tested (5 μL to 25 μL) are not statistically different (p=0.82), so this range of volumes is considered appropriate for measurements. A volume of 2.5 μL was also evaluated, but this volume of blood was not large enough to fill the 3 mm×3 mm aperture used in the spectrometer and thus gave highly variable results.
To help health workers gauge that a sufficiently large volume has been spotted on the paper, eight small dots may be laser printed onto the paper in the shape of a circle. This circle may hold roughly 10 μL of blood. This circle may also denote where the sodium deoxycholate lysing agent has been dried onto the paper.
Hemoglobin concentration from on-axis transmission measurement of blood spotted on paper were calculated. Patient blood samples were used to train and validate this algorithm on the laboratory spectrometer. Whole blood samples were obtained from 43 hospitalized patients. Venous blood was collected in heparinized tubes; anonymous specimens were obtained one week after collection. 3 patient samples were discarded because the blood showed significant clotting. Data from 20 samples were used to develop an algorithm relating the hemoglobin concentration as measured by HemoCue to the absorbance difference between two wavelengths using a best-fit power curve: [Hb] in g/dL=A*[Extinction coefficient(λ1)−extinction coefficient(λ2)]n, where A, λ1, λ2, and n were varied.
Patient blood samples were used to train and validate this algorithm on the laboratory spectrometer. Whole blood samples were obtained from 43 hospitalized patients. Venous blood was collected in heparinized tubes; anonymous specimens were obtained one week after collection. 3 patient samples were discarded because the blood showed significant clotting.
Two wavelengths are used: a hemoglobin absorption range from 350 nm to 600 nm where hemoglobin absorbs and a control absorption range from 600 nm to 750 nm where hemoglobin does not absorb. From 350 nm to 600 nm, spectra of blood on paper show characteristic absorbance peaks due to hemoglobin; above 600 nm, spectra show a nearly flat baseline region due to the paper substrate (
In one embodiment, data from 20 samples were used determine the absorbance difference between 528 nm and 656 nm to the hemoglobin concentration as measured by HemoCue using a best-fit power curve. Data from 20 samples were used to develop an algorithm relating the hemoglobin concentration as measured by HemoCue to the absorbance difference between two wavelengths using a best-fit power curve.
In one embodiment, the pair of wavelengths used were 528 nm and 656 nm. Data from the remaining 20 samples were used to validate the performance of this algorithm. The hemoglobin concentration for these samples was calculated from the transmission data using the relationship from the training set; results were comparable to those measured by the HemoCue. For both training and validation sets, a reading was taken on the spectrometer at 120 sec. after spotting.
Results from the training and validation sets for both the spectrometer and the low-cost reader are shown in
The WHO hemoglobin color scale also uses blood spotted on paper to determine hemoglobin concentration. With this method, a blood spot is compared to reference standards ranging from 4 g/dL to 14 g/dL in gradations of 2 g/dL. In non-optimal conditions such as poor lighting or inadequate training, however, accuracy can drop to ±4 g/dL. Van den Broek et al. reported that the color scale was within 2 g/dL of a laboratory hemoglobin value in only 67% of cases. (van den Broek, et al., Diagnosing anaemia in pregnancy in rural clinics: assessing the potential of the Haemoglobin Colour Scale. Bulletin of the World Health Organization. 1999; 77(1):15-21.) Thus, our spectrophotometric method has the potential to provide increased accuracy over the current paper-based method with comparable cost.
Example implementations of the present disclosure feature a reader to replace the spectrometer. Example of this reader are shown in
Light emitted from two LED diodes (HyperRed, λ=656±25 nm, 720-LHW5AM1T3T1LZ from Mouser Electronics (Mansfield, Tex.) and TrueGreen, 2, λ=528±33 nm, 720-LTWSSMJXKX36Z from Mouser Electronics) is collimated by plastic aspheric lenses (EFL=3.3 mm, NA=0.4, CAY033 from ThorLabs (Newton, N.J.)) and, after passing through 50/50 beamsplitter (BS007 from ThorLabs), is directed onto the sample. Light transmitted by the sample is detected by a broad-band photodiode (wavelength range: 350-1100 nm, FDS100 from ThorLabs) placed behind the sample chamber. In certain example implantations the electronic components of the system are connected to NI USB-6008 data acquisition module.
Samples may be inserted between two glass slides to protect the reader from biohazards; the glass slides may be reused. The chromatography paper may be cut such that aligning it with the bottom edge of the slide ensures proper alignment of the blood sample with the optics of the low-cost reader.
A LabVIEW program may take a one second baseline reading with both LEDs off to enable subtraction of ambient light, a two second reading with the hemoglobin absorption LED on, and a two second reading with the control LED on.
In certain example implementations, data is collected from the same samples in the training and validation sets described herein at 90 second after spotting. Data from the training set may be used to develop an algorithm relating the difference in transmission at 528 nm and 656 nm to the hemoglobin concentration as determined by the HemoCue. The algorithm was then used to predict the hemoglobin concentration for the 20 samples in the validation set using the concentration determined with the HemoCue as a comparison standard.
The apparatus of the present disclosure may a plurality of individual parts, as shown in
These individually manufactured parts may fit together as shown in Figure. 20. In that figure, a baseplate module is provided to hold other components. A circuit holder module is provided that is configured to be mated with the baseplate module and a detector modules. The detector module is configured to be mated with the baseplate and a sample holder module. The sample holder module is configured to be mated with the baseplate module, the detector module, and a beam splitter module. The beam splitter module is configured to be mated with the baseplate module, the sample holder module, and a lens module. The lens module is configured to be mated with the baseplate module, the beam splitter module, and an LED module. In certain implementations, the LED module is to hold a red LED, in other implementations, the LED module is to hold a blue LED. In still other implementations, the LED module is to hold a greed LED. As shown in
In certain implementations, the modules are modular to allow one or more components to be swapped out and the optical system to be customized. The low-cost reader my also be made to prevent disassembly, such as in cases where the reader will only be used for one type of test (e.g. hemoglobin concentration).
Certain implementations feature one more optical elements such as those shown in
Certain implementations feature one or more electrical detector and one more electrical sources, which as shown in
Certain implementations include a communication module, such as the module shown in
Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. While compositions and methods are described in terms of “comprising,” “containing,” or “including” various components or steps, the compositions and methods can also “consist essentially of” or “consist of” the various components and steps. All numbers and ranges disclosed above may vary by some amount. Whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the range is specifically disclosed. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee. Moreover, the indefinite articles “a” or “an,” as used in the claims, are defined herein to mean one or more than one of the element that it introduces. If there is any conflict in the usages of a word or term in this specification and one or more patent or other documents that may be incorporated herein by reference, the definitions that are consistent with this specification should be adopted.
The present application is a continuation of PCT/US12/70185 filed Dec. 17, 2012 which claims priority to U.S. Provisional Patent Application Ser. No. 61/576,851 filed Dec. 16, 2011, which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
61576851 | Dec 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US12/70185 | Dec 2012 | US |
Child | 14305790 | US |